Abbott and TAP Pharmaceutical settle NJ class action claiming violations of Prescription Drug Marketing Act in pricing Lupron®
Clients Abbott Laboratories and TAP Pharmaceutical Products Inc.
Jones Day represented Abbott Laboratories and TAP Pharmaceutical Products, Inc. in the defense of a New Jersey statewide class action alleging fraud, common law fraud and conspiracy in the pricing of its prostate cancer drug Lupron®.
Walker v. TAP Pharmaceutical Products et al. (N.J. Sup. Ct.)